Immunomodulatory therapies for COVID-19.

Front Med (Lausanne) · 2022 · PMC9381694 · PMID 35991665

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

There was also a numerical trend toward reduction in respiratory failure and mortality with use of CD24Fc (22 vs. 28%), but these results were not significant, as the study was not powered for these outcomes.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.